XML 45 R34.htm IDEA: XBRL DOCUMENT v3.20.2
Stock Plans and Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Assumptions Used in Determining Fair Value of Shares Issuable

The fair value of shares issuable under the ESPP is determined using the Black-Scholes option pricing model with the following weighted average assumptions: 

 

 

 

Six Months Ended

June 30,

 

 

 

2020

 

 

2019

 

Employee Stock Purchase Plan:

 

 

 

 

 

 

 

 

Expected term (in years) (1)

 

 

0.50

 

 

 

0.50

 

Expected volatility (2)

 

55%

 

 

45%

 

Risk-free interest rate (3)

 

0.29%

 

 

2.52%

 

Dividend rate (4)

 

0%

 

 

0%

 

 

(1)

The expected term represents the contractual term of the ESPP;

(2)

The expected volatility of the Company’s common stock on the date of grant is based on the weighted average of the Company’s historical volatility as a public company, the implied volatility of publicly-traded options on the Company’s common stock and the volatilities of publicly traded peer companies that are reasonably comparable to the Company’s own operations;

(3)

The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero coupon U.S. Treasury notes with maturities approximately equal to the expected term of the grant; and

(4)

The expected dividend yield is assumed to be zero as the Company has never paid dividends and has no current plans to pay any dividends on the Company’s common stock.

Schedule of Stock Option Activity

The following table summarizes the Company’s stock option activity:

 

 

 

Stock options

outstanding

 

 

Weighted

average

exercise price

 

Outstanding at December 31, 2019

 

 

723,383

 

 

$

26.56

 

Exercised

 

 

(186,215

)

 

 

24.63

 

Forfeited

 

 

(2,993

)

 

 

32.23

 

Outstanding at June 30, 2020

 

 

534,175

 

 

 

27.21

 

 

Schedule of Stock Options Outstanding, Vested and Expected to Vest and Exercisable

Stock options outstanding, vested and expected to vest and exercisable are as follows:

 

 

 

As of June 30, 2020

 

 

 

Number

of shares

 

 

Remaining

contractual

life (years)

 

 

Weighted-

average

exercise price

 

Outstanding

 

 

534,175

 

 

 

7.01

 

 

$

27.21

 

Vested and expected to vest

 

 

525,042

 

 

 

7.00

 

 

 

27.11

 

Exercisable

 

 

180,975

 

 

 

6.16

 

 

 

20.09

 

Schedule of Vested and Nonvested Stock Option Activity

Vested and nonvested stock option activity was as follows:

 

 

 

Vested

 

 

Nonvested

 

 

 

Options

outstanding

 

 

Weighted

average

exercise

price

 

 

Options

outstanding

 

 

Weighted

average

exercise

price

 

Outstanding at June 30, 2020

 

 

180,975

 

 

$

20.09

 

 

 

353,200

 

 

$

30.85

 

 

Summary of RSU and PSU Activity

The following table summarizes the Company’s RSU and PSU activity for the six months ended June 30, 2020:

 

 

 

Number of Shares

 

Outstanding at December 31, 2019

 

 

1,314,791

 

Granted

 

 

245,459

 

Vested

 

 

(66,113

)

Forfeited

 

 

(9,424

)

Outstanding at June 30, 2020

 

 

1,484,713

 

 

Summary of Stock-Based Compensation Expense

The Company recorded the total stock-based compensation expense as follows (in thousands):

 

 

 

Three Months Ended

June 30,

 

 

Six Months Ended

June 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Cost of revenue

 

$

703

 

 

$

412

 

 

$

1,311

 

 

$

847

 

Sales and marketing

 

 

3,917

 

 

 

2,547

 

 

 

7,525

 

 

 

4,915

 

Research and development

 

 

2,298

 

 

 

2,692

 

 

 

4,172

 

 

 

4,166

 

General and administrative

 

 

4,360

 

 

 

2,631

 

 

 

8,580

 

 

 

6,203

 

Total

 

$

11,278

 

 

$

8,282

 

 

$

21,588

 

 

$

16,131